Apelian David 4
4 · Eiger BioPharmaceuticals, Inc. · Filed Mar 13, 2020
Insider Transaction Report
Form 4
Apelian David
Director
Transactions
- Award
Stock Option (Right to Buy)
2020-03-12+10,000→ 10,000 totalExercise: $5.60Exp: 2030-03-11→ Common Stock (10,000 underlying) - Award
Common Stock
2020-03-12+5,000→ 5,000 total
Footnotes (2)
- [F1]Represents shares underlying Restricted Stock Units award that will vest on the first anniversary of the grant date of March 12, 2020.
- [F2]The option vests in equal monthly installments over 12 months measured from March 12, 2020 subject to Reporting Person's continuous service status as of each such date.